key: cord-0854097-rifp0ms7
authors: Lund, E.; Holden, M.; Busund, L.-T. R.; Snapkov, I.; Shvetsov, N.; Holden, L.
title: Trajectories of gene expression, seasonal influenza, and within-host seasonal immunity: transfer value to covid-19
date: 2022-03-11
journal: nan
DOI: 10.1101/2022.03.01.22271679
sha: 157ba1db7809cbb8eac003975b8a5e812f45666d
doc_id: 854097
cord_uid: rifp0ms7

As a novel approach we will combine trajectories or longitudinal studies of gene expression with information on annual influenza epidemics. Seasonality of gene expression in immune cells from blood could be a consequence of within-host seasonal immunity interacting with the seasonal pandemics of influenza (flu) in temperate regions and, thus, with potential valuable analogy transfer to the proposed seasonal development of covid-19. Here we operationalized within-host immunity as genes with both a significant seasonal term and a significant flu term in the sine-cosine model. Information on gene expression was based on microarray using RNase buffered blood samples collected randomly from a population-based cohort of Norwegian middle-aged women in 2003-2006, The Norwegian Women and Cancer (NOWAC) study. The unique discovery (N=425) and replication (N=432) design were based on identical sampling and preprocessing. Data on proportion of sick leaves due to flu, and the flu intensities per week was obtained from the National Institute of Public Health, giving a semi-ecological analysis. The discovery analysis found 2942 (48.1%) significant genes in a generalized seasonal model over four years. For 1051 within-host genes both the seasonal and the flu term were significant. These genes followed closely the flu intensities. The trajectories showed slightly more genes with a maximum in early winter than in late summer. Moving the flu intensity forward in time indicated a better fit 3-4 weeks before the observed influenza. In the replication analyses, 369 genes (35.1% of 1051) were significant. Exclusion of genes with unknown functions and with more than a season in difference reduced the number of genes in the discovery dataset to 305, illustrating the variability in the measurements and the problem in assessing weak biological relationships. Thus, we found for the first time a clear seasonality in gene expression with marked responses to the annual seasonal influenza in a unique discovery - replication design. Hypothetically, this could support the within-host seasonal immunity concept.

Regular recurrences of virus epidemics and sometimes pandemics like seasonal influenza, flu, have raised the question of within-host seasonal immunity as an evolutionary adaptation of the human immune systems to upcoming seasonal infections (1) . Temperature, humidity, and population density have been described over many centuries as important factors for spread of the infections (2) . The first wave of covid-19 in winter 2020 showed evidence of a seasonal disease (3, 4) . The third wave in 2022 in temperate regions of Europe and USA indicate that covid-19 behave as a seasonal virus (5). The seasonality of covid-19 is clearly demonstrated in the Norwegian number of deaths for the period February 2020 till January 2022, Figure 1 (6). The two diseases share the common nature of being mRNA virus but with important differences like influenza virus with negative sense and coronavirus with positive sense, among others (7, 8). These are two of the major zoonotic respiratory viruses with capabilities of a pandemic spread. Diagnostic tests based on gene expression from white blood cells at time of serious clinical disease have shown similarities between the two diseases, but also unique patterns of dysregulated expression compared to healthy state (9, 10). The last mutation SARS-CoV-2 omicron (11, 12) is more infectious, but with less clinical severity of infections than the first mutations of covid-19. Thus, covid-19 could emerge as a parallel to the seasonal influenza virus N1H1. A recent genomic study showed that a splice variant in OAS1 genes could be protective for COVID-19 (13), going back 60.000 years. There are indications of covid epidemics 25 000 years ago in Asia (14). Seasonal influenza had repeated mutations over the last centuries (7, 15). The pandemic in 1919 named the Spanish flu caused millions of deaths due to a N1H1 virus. The high mortality among young men during the first world war has been explained by a lack of immunity to those born after the 1889 "Russian flu". However, the 1889 "Russian flu" pandemic has also been described potentially as a coronavirus epidemic that could give ideas about the future handling of a seasonal covid-19 (16). This seasonality of virus infections during evolution could have changed the immune system in a seasonal direction. Several studies have shown seasonality of gene expression from immune cells (17, 18, 19) during the year. Some analyses included the effect of diagnosed virus infections but did not look at longitudinal effects of seasonal influenza. No general population studies have demonstrated repeated seasonality over years that also included information on seasonal influenza each year. The nature of this potential immunological . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 11, 2022. ; https://doi.org/10.1101/2022.03.01.22271679 doi: medRxiv preprint mechanism is not defined nor any specific gene involvement. A huge number of analyses of other immune parameters have found both seasonal and daytime variations (20, 21).

Within-host seasonal immunity can be operationalized in sine-cosine models as genes have both significant seasonal effects and flu effects, in contrast to genes with either significant seasonal or significant flu effects (22). A within-host seasonal immunity would have to be a Here we will describe for the first time the changes or trajectories in gene expression before, at and after the annual seasonal flu epidemics. We will take advantage of the national surveillance system (23) of seasonal influenza epidemics in Norway that reports the proportion of sick leaves from influenza like illnesses (ILI) as proportion of all sick leaves. The aim here is to explore the trajectories of gene expression or seasonal changes in relation to the annual epidemics of seasonal influenza searching for genes expressing within-host seasonal immunity.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 11, 2022. ; https://doi.org/10.1101/2022.03.01.22271679 doi: medRxiv preprint

The NOWAC study is a prospective study with recruitment of 172 000 women randomly sampled from the National Population Register in Norway invited between 1991 and 2007 (26). These women received a letter of invitation and a questionnaire, and additional questionnaires were sent out with intervals of four to six years. All participating women were followed up through linkage to national cancer and death registries based on the unique national identification number assigned to all residents of Norway.

The NOWAC study was approved by the Norwegian Data Inspectorate and recommended by the Regional Ethical Committee of Northern Norway (REC North). The linkages of the NOWAC database to national registries such as the Cancer Registry of Norway and registries on death and emigration have also been approved. The women were informed about these linkages in the letter of invitation. Furthermore, the collection and storing of human biological material was approved by the REC North in accordance with the Norwegian Biobank Act.

The linkages between Cancer Registry data and NOWAC study participants were performed at Statistics Norway, and the dataset was fully anonymized before it was made available to the authors. Information on breast cancer were used in this study to sample the random, matched controls. The Norwegian Data Protection Authority gave NOWAC exemption from the duty of confidentiality and permission to handle personal data (Datatilsynet, ref. 07/00030-2/cbr).

In 2003-2006, NOWAC participants born 1943-1957 were invited to participate in a subcohort: the NOWAC Post-genome Cohort (24) with the Post-genome biobank. The main purpose of this cohort was to establish a biobank suitable for analyses of functional genomics, in particular transcriptomics. Random samples of NOWAC participants were drawn in weekly batches of 500, until 50,000 women participated in. This gave a random date for each blood donation. These women completed a two paged questionnaire. Whole blood samples were collected by a general practitioner or at a health care institution, using the PAXgene Blood RNA collection kit (Preanalytix/Qiagen, Hombrechtikon, Switzerland), and were transported to the Institute of Community Medicine at UiT in Tromsø by overnight post for biological analyses. The PAXgene Blood RNA collection kit contains a buffer that lyses the blood cells and preserves the mRNA profile of the sample, allowing for long-term frozen storage and optimizing the sensitivity of analyses (27). The sampling was stopped for 6 weeks in the Norwegian summer holidays mostly from end of June till the beginning of August, and around Christmas.

These analyses were based on a split-sample strategy. Eligible Post-genome participants who were diagnosed with incident breast cancer were identified through linkage to the Cancer Registry of Norway. Each of these cases were assigned a matched control at random from the Post-genome cohort with the same birth year and same weekly batch of 500 invited women.

Information on cases were not used in this study. The persons used as controls represented a part of the study population without any known cancer diseases. The discovery and replication populations were both controls from two case-control studies of breast cancer. The discovery population consisted of 425 women used as controls in an analysis of gene expression trajectories before time of diagnosis (28). The replication used 432 women that had been controls in a study of changes in gene expression trajectories after a diagnosis of breast cancer (29). The distribution of the two studies according to sampling year is shown in Table 1 . is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 11, 2022. ; https://doi.org/10.1101/2022.03.01.22271679 doi: medRxiv preprint of patients on the patient list of general practitioners were used as denominators. The weekly recording period was from Friday to Thursday, after which the report card was completed and sent to NIPH. The national data provide a constant value for each week, here named Flu intensity. In the analyses weeks with no observations, the Flu intensity is set equal to 0.002 which is 2/3 of the smallest observed positive values. The data is smoothed with 15 days average.

All laboratory services were provided by the Genomics Core Facility, Norwegian University of Science and Technology, Trondheim, Norway. To control for technical variability such as different batches of reagents and kits, day-to-day variations, microarray production batches, and effects related to different laboratory operators, the original case-control pair was kept together throughout all extraction, amplification, and hybridization procedures. Total RNA extraction was performed using the PAXgene Blood RNA kit (Preanalytix/Qiagen, Hombrechtikon, Switzerland) according to the manufacturer's instructions. RNA quality and purity were assessed using the NanoDrop ND 8000 spectrophotometer (ThermoFisher Scientific, Wilmington, DE, USA) and Agilent bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). RNA amplification was performed on 96-wells plates using 300 ng of total RNA and the Illumina TotalPrep-96 RNA Amplification Kit (Ambio, Inc., Austin, TX, USA). The mRNA amplification procedure consisted of using a oligo(dT) primer for reverse transcription with a T7 promoter-specific ArrayScript reverse transcriptase, followed by a second-strand synthesis. In vitro transcription with T7 RNA polymerase using a biotin-NTP mix produced biotinylated cRNA copies of each mRNA in the sample.

The discovery samples were run on the Illumina Human Hu-6. The replication samples were run on the Illumina HumanHT-12 version 4 bead chip array (Illumina, San Diego, California, USA). The last one had half the beads of the first, see Appendix Figure A . Outliers were detected using the R-package nowaclean (30), based on visual examination of dendrograms, principal component analysis plots and density plots. Individuals that were considered borderline outliers were excluded if their laboratory quality measures were below given thresholds (RIN value <7, 260/280 ratio <2, 260/230 ratio <1.7, and 50 < RNA < 500). All laboratory work was done consecutively for all controls in 2012. The total number of genes were 25 212.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 11, 2022. ; https://doi.org/10.1101/2022.03.01.22271679 doi: medRxiv preprint

The procedures for the preprocessing are given in (30). The discovery dataset consisted finally of 430 controls after exclusions of non-eligible and the replication set of 432 controls.

The resulting datasets was then background corrected using negative control probes, log 2 transformed using a variance stabilizing technique (31), and quantile normalized. We retained probes present in at least 90% of women. A probe was defined as present for an individual if its detection p value was less than 0.01 for that individual. The set points for these two parameters were stricter than in previous analyses leaving fewer genes with small variations.

If a gene was represented with more than one probe, the average expression of the probes was used as the expression value for the gene. The probes were translated to genes using the lumiHumanIDMapping database (32). The two largest principal components of the two data set were used for outlier control, see Appendix Figure B . We removed five observations from the original discovery data set that were outliers in the second principal component leaving 425 samples for the analyses. After preprocessing the discovery dataset had 6118 genes and the replication data set 6348 genes. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 11, 2022. ; https://doi.org/10.1101/2022.03.01.22271679 doi: medRxiv preprint

We used the Discovery and Replication datasets in Table 1 for estimating the parameters in the models and testing the hypothesis described in Statistical Models.

The model with only a seasonal term, model A, was applied on the Discovery dataset. This gave 2942 significant genes of 6118 genes (FDR 5%). Of the 2942 significant genes, 416 had log fold change (ܿ ) larger than 0.2. Figure 3 shows the seasonal variation of the 2942 genes.

There were clear seasonal effects both in a summer and a winter season. Note that there were few observations during summer vacation and at the end of December.

As shown in Figure The left panel in Figure 4 shows that mainly the same genes (1983 genes) have a significant seasonal term or a flu term when the model only includes one of the two terms. 959 genes only have a significant seasonal term, and 611 genes only have a significant flu term. Hence these terms mainly describe the same variability in the gene expressions. The seasonal term has the flexibility to set the maximum gene expression at any date during the year. For most . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 11, 2022. ; https://doi.org/10.1101/2022.03.01.22271679 doi: medRxiv preprint genes the estimated season has its maximum or minimum value in February which is close to the average annual maximum value of the flu-observations. Hence, the seasonal variation for most genes may be explained by the flu variation. This indicates that the flu intensity may be a main driver in determining the seasonal variability of the gene expression. Table 2 shows that it is slightly more usual that the genes are up regulated with the flu (1488 genes) than , to find out whether the change in the gene expression was mainly before, at the same time or after the changes in the flu intensity. The top panel in Figure 8 shows that the number genes with significant flu term or significant flu and at least one seasonal term were largest when the flu term was moved around three weeks forward. The number of genes with significant seasonal terms and no flu term was lowest when the flu term was 5 days later than the actual data. In total, this indicates that the main change in the genes Table 3 is divided into sections marked with boldface for when the genes obtained the most extreme values. All the listed genes have a significant flu term, but in most cases not in the entire period, (-60,60) days.

We tested the hypothesis whether the covariation of the gene expressions and the flu intensity was due to a subgroup of individuals. In the null hypothesis, we assumed that the residuals ε ,

were symmetric around zero with the alternative hypothesis that we obtain large values of the residual when ε , ݄ 0 is large. The results are shown in Table 4 . We were not able to reject the hypothesis that the residuals are symmetric. Hence, we may not conclude that the observed correlation between the gene expression and the observed flu intensity was due to a subgroup of individuals. In the table, ݇ represents the potential number of individuals with the . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 11, 2022. ; https://doi.org/10.1101/2022.03.01.22271679 doi: medRxiv preprint most extreme residuals that potentially could dominate the covariation between the gene expressions and the flu intensity observations. The smaller ݇ is, the more extreme must the residuals be to influence the covariation with the flu intensity for the entire sample. Among the 305 genes, negative ݄ values were found in 148 genes (Appendix Table 1 ) while 157 genes (Appendix Table 2 

T o r e d u c e n o i s e i n t h e d a t a b e f o r e i n t e r p r e t a t i o n s o f t h e g e n e s , a r e p l i c a t i o n a n a l y s i s w a s p e r f o r m e d f o r t h e 1 0 5 1 w i t h i n - h o s t g e n e s w i t h b o t h a s i g n i f i c a n t

A detailed in-depth investigation of the significant single genes and their functions was not among the aims of this work, but we include Tables 5A and 5B that summarize the functions of the top 20 genes for positive and negative flu coefficients, respectively. Additionally, we performed a pathway-level assessment of all significant genes associated with negative and positive ݄ values using the Reactome database (data not shown). Generally, the number of significant pathways (p < 0.05) was higher for the ݄ negative group of genes (263 against . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 11, 2022. ; https://doi.org/10.1101/2022.03.01.22271679 doi: medRxiv preprint 49). Potentially, this can be explained by a more converged state of the immune system prepared for meeting oncoming infection.

So far in the analyses the only criteria for inclusion into the analyses was the p-values. In epidemiology this is always combined with a measure of relative risk. Here the fold change is the value of gene expression at the maximum compared to the average. A low fold change describes a very flat seasonal curve. Introducing a limit of log fold change => 0.1 or a fold change of 1.05, (5 % increase), reduced the number of genes significantly in both the Discovery and Replication datasets to 281, Table 6 .

A list of genes in a test for pneumonia infections like seasonal influenza and covid-19 was published recently (9). The test contains 36 genes as signature, Table 7 . The number of genes available for analyses in our study depended on the different criteria in the preprocessing. More stringent criteria for detection limit decreased the number of genes. In a comparison of the genes in the test with the 1051 within-host list of our study, only one gene, GBP1, was in both lists.

Lastly, in another analysis of covid-19 and severity of the disease (13) the genes OAS 1,2,3 were found to be protective. These genes were not significant in this study, Table 8 .

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 11, 2022. ; https://doi.org/10.1101/2022.03.01.22271679 doi: medRxiv preprint

This analysis has, for the first time to our knowledge, found a strong covariation between seasonal influenza and annual changes in gene expression for a subset of genes from immune cells in peripheral blood. The trajectories of these genes showed both a significant coefficient for annual seasonal changes and a flu determined term. The peaks of the gene expression level were observed to change concomitantly with the peaks of the epidemics independent of the month of the peak. The findings should have been externally validated in other studies, but a thorough search in Medline did not reveal similar studies (Box 1).

These findings support our operationalized within-host concept at a population level. Withinhost seasonal immunity is a rather unspecified concept and the lack of knowledge on how the seasonality of these genes changes the immune system is challenging (1, 2, 5, 8) . The applied definition of both a seasonal term and a flu term in the model could be one way of searching for genes participating in within-host seasonal immunity. From a total of 1000 genes with both terms significant the number was reduced to three hundred in the discovery -replication analyses.

These results indicate that during an influenza epidemic or pandemic changes occur on a population level for some genes. The regular seasonal pattern and the flu driven peaks indicates a relationship between these two. There were two major patterns of gene expression. The changes in gene expression represented all infected women in the study population.

During the epidemic as many as five percent of the total work force of around 2.5 million could have a sick leave for influenza in one week (Figure 1 ). Around 70% of women aged 16-74 were working. The participating women were middle aged and mainly aged 45-65 years at time of blood sampling. Using hypothesis testing, we were not able to show that the effect was due to a small group of infected people. That would have supported that the flu gene expression was due to the numbers of women with flu in the population.

From the end of 2021 a third wave of COVID-19 moves over the temperate regions of Europe and US (11). The seasonality of deaths due to the pandemic in Norway (Figure 1) demonstrates the three waves. The similarities with the years described here for seasonal influenza is striking ( Figure 2 ). The covid-19 pandemic display new waves due to novel mutations, similar to seasonal influenza. The mutations give diseases with different symptoms and severity. Consequently, knowledge about the spread of seasonal influenza and a potential within-host seasonal immunity could have a transfer value to corona viruses (35). There are a few studies of covid-19 with results that implicit support of our view. In a study of blood gene expression profiles in patients admitted to emergency wards, strong transcriptional responses were found not only in COVID-19, but also for seasonal coronavirus, influenza, bacterial pneumonia, and healthy controls (9, 10). Proposed classifiers for the different serious infections and healthy controls showed auROC (mean area under the receiver operating characteristic curve) close to 1.0. However, of the 36 genes in the test only one was found among the 1051 genes named within-host genes here. Thus, the genes involved in the acute phase of serious disease did not confound the within-host genes. However, the healthy group of the control panel consisted of only 6 women, all 20 years. The lack of consistency between the within-host flu genes and the acute phase genes defined by the gene expression test could support our interpretations. Recently, the genes OAS 1,2,3 were found to be associated with improved survival of covid-19 (13). The genes did exist in our datasets, but only OAS1 passed the preprocessing limit. OAS1 did not reach significant expression level in the sinecosine model.

The seasonal influenza epidemics showed for three of the four years of observation approximately the same pattern with infection rates increasing early in winter lasting for a few . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The seasonal patterns of genome-wide gene expression have been investigated in several studies (17, 18, 19) . The same statistical model as used here were applied in other analyses with focus on summer and winter effects. The number of genes with significant seasonality varied among the studies. In a German study, 2311genes were upregulated in the summer and 2826 genes upregulated in the winter or 23% of all tested genes (17). They defined seasonal effect as positive relative effect in January, February, and December and negative in June, July and August. Another study from Australia (19) found less than two hundred significant seasonal genes. Lastly (18), a US study found 898 significant transcripts. These three studies were based on clinical studies of individuals with risk of prediabetes (36), children with increased risk of type I diabetes (37), and a study of familial melanoma (38). The models used by us were qualitatively very different and gave much more information opening for maximum response any date in the year. In the previous mentioned German study, the original analyses found a total of 5137 significant genes (17). This was reduced to 179 or 4% in an external validation study comparing the original findings with five samples from a multi-center study. Here the 1051 significant within-host genes were reduced to 305 or 30% in the replication analysis. One reason for the different results could be the design of the studies. By introducing a discovery -replication design the internal validity of the results in our study was verified. We are not aware of other studies looking at seasonal virus diseases that could be used for an external validation of our findings (Box 1).

It was recommended from the early beginning of gene expression analyses to use split sample methodology to control for weak associations and biases like technology sampling methods and preprocessing (39). Split sample analyses will have lower statistical power compared to using all samples in an explorative design. Here we used a split sample design with discovery and replication studies (25). The conditions for a good replication design are that the discovery (original) and the replication (confirmatory) populations are similar in terms of sex, age, ethnicity, and other important factors. In addition, the two studies should share identical laboratory analyses, data processing pipelines and analytical approaches. Thus, a replication study is methodologically different from studies of external validity. The replication analyses showed that many weak associations could not be reproduced. This reduced the problem of . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Interpretation of significance solely on the p-values have given a very large number of significant genes in almost all analyses of seasonal gene expression, here close to 3 000. This could indicate that the strong parametrization of the sine -cosine model without replication design leads to many false positive results. For many decades epidemiology has relied more on relative risks than p-values alone (40). In functional genomics fold change is used as term for the difference between maximum amplitude and the average value for each gene. The introduction of a limit of the log fold change of 0.1 reduced the number of genes somewhat in a common analysis of the discovery and replication datasets. A log fold change less than 0.1 is equal to a relative risk of less than 5%. Such low risks can easily be confounded.

The study design has some limitations. The discovery and the replication samples were run on two different microarrays. The discovery set used Illumina H-6 with six blood samples on the chip, compared to the 12 blood samples on the Illumina Hu-12 in the replication. The shift was due to the sudden stop in the production of Illumina Hu-6. Hu-6 had approximately twice as many probes per gene as Hu-12 (Appendix Figure A) . It might be that the reduction in probe numbers per gene reduced the sensibility of the microarray. Still a reasonable test-retest result was obtained. The original NOWAC study invited only women since it was based on hypotheses related to female reproduction, oral contraception, and hormonal replacement therapy. The age span included mainly women in their middle age. Due to the original design of building a biobank for functional genomics the study covered only four years. On the other hand, the sampling was independent of any knowledge of seasonal influenza.

A major issue in the interpretation of the findings is the lack of knowledge about many basic aspects of the antibody response to the influenza A virus (15). This makes it difficult to test specific hypotheses. Preliminary analyses of the gene expression did not support any specific hypothesis. This could be due to lack of knowledge of the biological relationship between host and viruses.

A major strength of this study was the completely random assignment for blood sampling regardless of place of living in Norway. Due to the extended sampling period, the design covered four years with different timing of the annual seasonal influenza. This populationbased design increased the validity of the findings. As a national representative cohort, we could use national representative sickness data collected by the National Institute of Public . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 11, 2022. ; https://doi.org/10.1101/2022.03.01.22271679 doi: medRxiv preprint

We are thankful to all the women who donated blood samples to the NOWAC biobank.

Bente Augdal and Merete Albertsen are thanked for their work on all infrastructure and administrative issues. We are grateful to Heidi Grønn for technical support. We are thankful for the valuable proof-reading of the English text by prof. emeritus Lise L.

Håheim. Data available statement: Data will be available on request according to Norwegian health research law. Please contact corresponding author.

The authors have declared that no competing interests exist.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 11, 2022. . Within each section, the genes are sorted after size of ݄ where the most extreme value is obtained. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 11, 2022. .

The probability for rejecting the hypothesis (p-value) that the residuals are symmetric based on 10,000 simulations. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 11, 2022. ; https://doi.org/10.1101/2022.03.01.22271679 doi: medRxiv preprint M  G  C  5  2  0  0  0  P  r  o  p  o  s  e  d  t  o  b  e  i  m  p  l  i  c  a  t  e  d  i  n  T  -c  e  l  l   p  r  o  l  i  f  e  r  a  t  i  o  n  a  n  d  e  f  f  e  c  t  o  r  f  u  n  c  t  i  o  n  .  I  n   d  e  n  d  r  i  t  i  c  c  e  l  l  s  i  n  v  o  l  v  e  d  i  n  e  n  d  o  s  o  m  e  t  o  -m  e  m  b  r  a  n  e  r  e  c  y  c  l  i  n  g  o  f  m  a  j  o  r   h  i  s  t  o  c  o  m  p  a  t  i  b  i  l  i  t  y  c  o  m  p  l  e  x  (  M  H  C . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) G  e  n  e  F  u  n  c  t  i  o  n  I  m  m  u  n  o  l  o  g  i  c  f  u  n  c  t  i  o  n   V  N  N  2  P  a  r  t  i  c  i  p  a  t  e  i  n  h  e  m  a  t  o  p  o  i  e  t  i  c  c  e  l  l   t  r  a  f  f  i  c  k  i  n  g  a  n  d  t  r  a  n  s  e  n  d  o  t  h  e  l  i  a  l   m  i  g  r  a  t  i  o  n  o  f  n  e  u  t  r  o  p  h  i  l  s   U  p  r  e  g  u  l  a  t  e  d  i  n  i  n  f  l  u  e  n  z  a  i  n  v  i  t  r . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) c  e  l  l  u  l  a  r  r  e  t  i  n  o  l  -b  i  n  d  i  n  g  p  r  o  t  e  i  n  -b  o  u  n  d   r  e  t  i  n  a  l  .  M  a  y  o  x  i  d  i  z  e  o  t  h  e  r  a  l  d  e  h  y  d  e  s   i  n  v  i  v  o  .  A  l  c  o  h  o  l  m  e  t  a  b  o  l  i  s  m   H  I  A  T  1  E  n  c  o  d  e  s  n  e  u  r  o  n  a  l  p  r  o  t  e  i  n  .  F  u  n  c  t  i  o  n  i . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 11, 2022. ; https://doi.org/10.1101/2022.03.01.22271679 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 11, 2022. ; https://doi.org/10.1101/2022.03.01.22271679 doi: medRxiv preprint I  F  I  6  I  F  I  6  I  F  I  6  I  F  I  6   1  4  I  F  I  T  1  I  F  I  T  1  I  F  I  T  1  I  F  I  T  1   1  5  I  F  I  T  2  I  F  I  T  2  I  F  I  T  2  I  F  I  T  2   1  6  I  F  I  T  3  I  F  I  T  3  I  F  I  T  3  I  F  I  T  3   1  7  I  F  I  T  5  I  S  G  1  5  I  S  G  1  5  I  S  G  1 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 11, 2022. ; https://doi.org/10.1101/2022.03.01.22271679 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 11, 2022. ; https://doi.org/10.1101/2022.03.01.22271679 doi: medRxiv preprint

Drivers of Infectious Disease Seasonality: Potential Implications for COVID-19

Seasonality of Respiratory Viral Infections

Cold and dry winter conditions are associated with greater SARS-CoV-2 transmission at regional level in western countries during the first epidemic wave. Sci Rep

Plot of the distribution of the beads for the same gene VVN2 from Hu-6 (discovery dataset) and Hu-12 (replication dataset.